Results 261 to 270 of about 2,934,165 (348)

Antimicrobial properties and toxicity challenges of chlorine dioxide used in alternative medicine. [PDF]

Sci Rep
Dudek-Wicher R, Brożyna M, Paleczny J, Mączyńska B, Dudek B, Migdał P, Dołowacka-Jóźwiak A, Fischer J, Junka A.   +8 more
europepmc   +1 more source

Tumour–host interactions in Drosophila: mechanisms in the tumour micro‐ and macroenvironment

Molecular Oncology, EarlyView.
This review examines how tumour–host crosstalk takes place at multiple levels of biological organisation, from local cell competition and immune crosstalk to organism‐wide metabolic and physiological collapse. Here, we integrate findings from Drosophila melanogaster studies that reveal conserved mechanisms through which tumours hijack host systems to ...
José Teles‐Reis, Tor Erik Rusten
wiley   +1 more source

Does anxiety influence the use of complementary or alternative medicine among cancer patients? [PDF]

J Cancer Res Clin Oncol
Heyder C, Büntzel J, Boyadzhiev H, Stegmaier P, Zomorodbakhsch B, Heißner K, Stoll C, von Weikersthal LF, Czekay J, Rudolph I, Hübner J.   +10 more
europepmc   +1 more source

Complementary and Alternative Medicine Use for HIV Management in the State of Florida: Medical Monitoring Project

, 2016
Natalie E. Chichetto, Chukwuemeka N. Okafor, Jeffrey S. Harman, Shantrel Canidate, Christa Cook, Robert L. Cook   +5 more
openalex   +1 more source

Basroparib inhibits YAP‐driven cancers by stabilizing angiomotin

Molecular Oncology, EarlyView.
Basroparib, a selective tankyrase inhibitor, suppresses Wnt signaling and attenuates YAP‐driven oncogenic programs by stabilizing angiomotin. It promotes AMOT–YAP complex formation, enforces cytoplasmic YAP sequestration, inhibits YAP/TEAD transcription, and sensitizes YAP‐active cancers, including KRAS‐mutant colorectal cancer, to MEK inhibition.
Young‐Ju Kwon, Dong Young Kim, Yuna Kim, Uk‐Il Kim, Jae‐Sung Kim   +4 more
wiley   +1 more source

A Comprehensive Look at Complementary and Alternative Medicine (CAM) in Saudi Arabia: A Meta-Analysis Study. [PDF]

Health Sci Rep
Alsanad SM.
europepmc   +1 more source

Cotargeting TREM2 and IL2 pathways triggers multipronged anticancer immunity

Molecular Oncology, EarlyView.
Von Locquenghien et al. report that MiTE‐144, a triggering receptor expressed on myeloid cells 2 (TREM2) blocking antibody fused to interleukin‐2 (IL2) variant with tumour microenvironment restricted activation, demonstrates superior anticancer efficiency in a preclinical setting.
Isaure Vanmeerbeek, Jenny Sprooten, Abhishek D. Garg   +2 more
wiley   +1 more source

Parental management of autoimmune disease with complementary and alternative medicine: a scoping review of the literature in OECD countries. [PDF]

BMC Complement Med Ther
Maio J, Smith CA, Ward PR.
europepmc   +1 more source

RaMBat: Accurate identification of medulloblastoma subtypes from diverse data sources with severe batch effects

Molecular Oncology, EarlyView.
To integrate multiple transcriptomics data with severe batch effects for identifying MB subtypes, we developed a novel and accurate computational method named RaMBat, which leveraged subtype‐specific gene expression ranking information instead of absolute gene expression levels to address batch effects of diverse data sources.
Mengtao Sun, Jieqiong Wang, Shibiao Wan
wiley   +1 more source

Editorial: Rehabilitation and alternative medicine in the healthcare for chronic rheumatic pain disorders. [PDF]

Front Med (Lausanne)
Fu TC, Lane NE, Lee SH, Chen JC, Hsu SF, Chang CM.   +5 more
europepmc   +1 more source